top-left-banner

Monday, Sep 01st

Last update06:09:18 AM GMT

TwitterLinkedinYoutubeGoogleFeed

Banner

User1

User2c

User3

You are here: BioMedTech

BioMedTech

Top medic boosts PneumaCare’s US growth

Pneumacare CEO, Ward HillsA major hire in the US has boosted the North American growth strategy of Cambridge medical technology company PneumaCare.

Cambridge software a sound investment

Photograph credit: Jonas BergstenA new software product developed by researchers at Cambridge University could greatly improve sound perception for users of hearing aids.

Cambridge brain surgeons pioneer 3D technology

World-leading teaching hospital Addenbrooke’s in CambridgeBrain surgeons at world-leading teaching hospital Addenbrooke’s in Cambridge are pioneering new 3D technology in the UK.

Cambridge sweeps board in medtech awards

Dr Mohammad Al‐UbaydliCambridge UK healthcare companies ended up sweeping the board by winning all three categories of the inaugural Janssen Connected Health Challenge Europe 2012 at Health 2.0 in Berlin.

Fertility firm on top of the world

Shamus Husheer, CTC’s CEOsCambridge Temperature Concepts has scooped another global accolade by being named startup of the year in Johnson & Johnson's inaugural European Connected Health Challenge.

Valley-Cambridge personalised medicines alliance

Dr Darrin Disley, CEO of HorizonSilicon Valley translational medicines giant, Crown Bioscience, Inc. and Cambridge UK personalised medicines pioneer Horizon Discovery have forged an alliance to accelerate cures for cancer geared to sufferers’ individual genetic make-up.

Big Pharma locks into Cambridge drug advance

CEO Eddy LittlerDomainex Ltd, a Cambridge UK drug discovery company, has stirred the interest of global pharmaceutical giants with technology advances in the fields of psoriasis and Chronic Obstructive Pulmonary Disease (COPD).

Pedersen creates stem cell drug powerhouse

Professor Roger Pedersen. Image copyright – 2012 University of CambridgeA Cambridge University technology team that developed a way to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors.

Page 52 of 124